Shanghai Kehua Bio-EngineeringLtd 관리

관리 기준 확인 1/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Ming Li

최고 경영자

CN¥2.0m

총 보상

CEO 급여 비율	n/a
CEO 임기	1.6yrs
CEO 소유권	n/a
경영진 평균 재임 기간	1.6yrs
이사회 평균 재임 기간	less than a year

최근 관리 업데이트

Recent updates

CEO

Ming Li (48 yo)

1.6yrs

테뉴어

CN¥1,955,600

보상

Mr. Ming Li is President of Shanghai Kehua Bio-Engineering Co.,Ltd from April 3, 2023 and serves as its Director since June 28, 2023 and has been its Chairman since March 20, 2024. He is employed at Shangh...

리더십 팀

이름	위치	테뉴어	보상	소유권
Ming Li	Chairman & President	1.6yrs	CN¥1.96m	데이터 없음
Fang Luo	CFO & Financial Director	8.8yrs	CN¥1.38m	0.019% CN¥ 639.7k
Chao Chen	Senior Vice President	1.6yrs	CN¥2.51m	데이터 없음
Baogang Miao	VP & Non-Independent Director	less than a year	CN¥1.81m	데이터 없음
Jiaming Liang	VP & Non-Independent Director	less than a year	CN¥894.80k	데이터 없음
Hongying Jin	VP, Board Secretary & Non Independent Director	1.9yrs	CN¥1.08m	데이터 없음
Shin Kang Hyuk	Vice President	1.3yrs	CN¥403.80k	데이터 없음

1.6yrs

평균 재임 기간

48yo

평균 연령

경험이 풍부한 관리: 002022 의 관리팀은 경험 (평균 재직 기간 1.6 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Ming Li	Chairman & President	1.4yrs	CN¥1.96m	데이터 없음
Baogang Miao	VP & Non-Independent Director	less than a year	CN¥1.81m	데이터 없음
Jiaming Liang	VP & Non-Independent Director	less than a year	CN¥894.80k	데이터 없음
Hongying Jin	VP, Board Secretary & Non Independent Director	1.4yrs	CN¥1.08m	데이터 없음
Zhenxi Zhang	Independent Director	less than a year	데이터 없음	데이터 없음
Hou Wei	Employee Representative Supervisor	less than a year	데이터 없음	데이터 없음
Zhichao Ma	Vice Chairman	2.2yrs	데이터 없음	데이터 없음
Chuanfang Zheng	Independent Director	1.4yrs	CN¥75.00k	데이터 없음
Chao Yi	Chairman of the Supervisory Board	1.4yrs	데이터 없음	데이터 없음
Niancai Peng	Non-Independent Director	less than a year	데이터 없음	데이터 없음
Wenhua Shan	Independent Director	less than a year	데이터 없음	데이터 없음
Xiaotian Yang	Supervisor	less than a year	데이터 없음	데이터 없음

0.7yrs

평균 재임 기간

48yo

평균 연령

경험이 풍부한 이사회: 002022 의 이사회는 경험(평균 재직 기간 0.7 년)으로 간주되지 않으므로 새 이사회가 필요합니다.

Shanghai Kehua Bio-EngineeringLtd 관리

관리 기준 확인 1/4

주요 정보

최근 관리 업데이트

Shanghai Kehua Bio-Engineering Co.,Ltd, Annual General Meeting, Apr 19, 2024

High number of new directors

Shanghai Kehua Bio-Engineering Co.,Ltd Approves Management Appointments

High number of new and inexperienced directors

Shanghai Kehua Bio-Engineering Co.,Ltd Announces Directorate Changes

Shanghai Kehua Bio-Engineering Co.,Ltd, Annual General Meeting, Jun 30, 2022

Recent updates

Third quarter 2024 earnings released: CN¥0.14 loss per share (vs CN¥0.08 loss in 3Q 2023)

New minor risk - Share price stability

Shanghai Kehua Bio-Engineering Co.,Ltd to Report Q3, 2024 Results on Oct 22, 2024

New major risk - Revenue and earnings growth

Second quarter 2024 earnings released: CN¥0.047 loss per share (vs CN¥0.065 loss in 2Q 2023)

Shanghai Kehua Bio-Engineering Co.,Ltd to Report First Half, 2024 Results on Aug 30, 2024

First quarter 2024 earnings released: CN¥0.057 loss per share (vs CN¥0.11 profit in 1Q 2023)

Shanghai Kehua Bio-Engineering Co.,Ltd to Report Q1, 2024 Results on Apr 29, 2024

Shanghai Kehua Bio-Engineering Co.,Ltd, Annual General Meeting, Apr 19, 2024

Full year 2023 earnings released: CN¥0.46 loss per share (vs CN¥1.89 profit in FY 2022)

New minor risk - Share price stability

Now 21% undervalued

Shanghai Kehua Bio-Engineering Co.,Ltd to Report Fiscal Year 2023 Results on Apr 27, 2024

Third quarter 2023 earnings released: CN¥0.08 loss per share (vs CN¥0.90 profit in 3Q 2022)

Shanghai Kehua Bio-Engineering Co.,Ltd to Report Q3, 2023 Results on Oct 28, 2023

Second quarter 2023 earnings released: CN¥0.065 loss per share (vs CN¥0.047 profit in 2Q 2022)

High number of new directors

Shanghai Kehua Bio-Engineering Co.,Ltd to Report First Half, 2023 Results on Aug 17, 2023

Shanghai Kehua Bio-Engineering Co.,Ltd Approves Management Appointments

Upcoming dividend of CN¥0.60 per share at 4.9% yield

Full year 2022 earnings released: EPS: CN¥1.89 (vs CN¥1.66 in FY 2021)

High number of new and inexperienced directors

Third quarter 2022 earnings released: CN¥0.019 loss per share (vs CN¥0.49 profit in 3Q 2021)

Shanghai Kehua Bio-Engineering Co.,Ltd Announces Directorate Changes

Second quarter 2022 earnings released: EPS: CN¥0.047 (vs CN¥0.26 in 2Q 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Shanghai Kehua Bio-Engineering Co.,Ltd Announces Final Dividend on A Shares for the Year 2021, Payable on July 19, 2022

Shanghai Kehua Bio-Engineering Co.,Ltd, Annual General Meeting, Jun 30, 2022

Investor sentiment improved over the past week

Shanghai Kehua Bio-Engineering Co.,Ltd Proposes Dividend for 2021

First quarter 2022 earnings released: EPS: CN¥0.043 (vs CN¥0.67 in 1Q 2021)

High number of new and inexperienced directors

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

High number of new and inexperienced directors

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Shanghai Kehua Bio-Engineering Co.,Ltd Announces Final Profit Distribution Proposal for 2020

First quarter 2021 earnings released: EPS CN¥0.67 (vs CN¥0.098 in 1Q 2020)

Full year 2020 earnings released: EPS CN¥1.31 (vs CN¥0.40 in FY 2019)

New 90-day low: CN¥15.12

New 90-day low: CN¥15.37

Investor sentiment deteriorated over the past week

New 90-day low: CN¥16.73

New 90-day low: CN¥17.37

Third quarter earnings released

Market bids up stock over the past week

First half earnings released

Shanghai Kehua Bio-Engineering Co.,Ltd to Report First Half, 2020 Results on Aug 28, 2020

New 90-day high - CN¥24.27

CEO

테뉴어

보상

리더십 팀

평균 재임 기간

평균 연령

이사회 구성원

평균 재임 기간

평균 연령